vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and PAVmed Inc. (PAVM). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $996.0K, roughly 1.2× PAVmed Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs -858.5%, a 7324.3% gap on every dollar of revenue. On growth, PAVmed Inc. posted the faster year-over-year revenue change (25.9% vs 3.3%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.
LUCD vs PAVM — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $996.0K |
| Net Profit | $-10.4M | $64.4M |
| Gross Margin | — | -38.7% |
| Operating Margin | -971.0% | -1162.4% |
| Net Margin | -858.5% | 6465.8% |
| Revenue YoY | 3.3% | 25.9% |
| Net Profit YoY | 16.0% | 464.4% |
| EPS (diluted) | $-0.10 | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.2M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $828.0K | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $1.2M | $996.0K | ||
| Q2 24 | $976.0K | $979.0K | ||
| Q1 24 | $1.0M | $1.0M | ||
| Q4 23 | $1.0M | $1.0M |
| Q3 25 | $-10.4M | — | ||
| Q2 25 | $-4.4M | — | ||
| Q1 25 | $-26.9M | — | ||
| Q4 24 | $-11.5M | — | ||
| Q3 24 | $-12.4M | $64.4M | ||
| Q2 24 | $-11.0M | $-10.8M | ||
| Q1 24 | $-10.6M | $-15.2M | ||
| Q4 23 | $-10.8M | $-14.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -38.7% | ||
| Q2 24 | — | -70.2% | ||
| Q1 24 | — | -72.7% | ||
| Q4 23 | — | -53.5% |
| Q3 25 | -971.0% | — | ||
| Q2 25 | -978.8% | — | ||
| Q1 25 | -1508.1% | — | ||
| Q4 24 | -1033.8% | — | ||
| Q3 24 | -997.8% | -1162.4% | ||
| Q2 24 | -1146.7% | -1397.8% | ||
| Q1 24 | -1078.1% | -1389.7% | ||
| Q4 23 | -1101.3% | -1561.7% |
| Q3 25 | -858.5% | — | ||
| Q2 25 | -381.7% | — | ||
| Q1 25 | -3249.8% | — | ||
| Q4 24 | -964.2% | — | ||
| Q3 24 | -1055.5% | 6465.8% | ||
| Q2 24 | -1127.6% | -1105.9% | ||
| Q1 24 | -1060.1% | -1506.1% | ||
| Q4 23 | -1041.3% | -1338.0% |
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.52 | — | ||
| Q4 24 | $-0.17 | — | ||
| Q3 24 | $-0.25 | $1.44 | ||
| Q2 24 | $-0.23 | $-1.19 | ||
| Q1 24 | $-0.40 | $-2.62 | ||
| Q4 23 | $-0.25 | $-1.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $765.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $-4.9M |
| Total Assets | $53.2M | $30.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $47.3M | — | ||
| Q2 25 | $31.1M | — | ||
| Q1 25 | $25.2M | — | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $14.5M | $765.0K | ||
| Q2 24 | $24.9M | $25.5M | ||
| Q1 24 | $24.8M | $25.5M | ||
| Q4 23 | $18.9M | $19.6M |
| Q3 25 | $25.8M | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $6.3M | $-4.9M | ||
| Q2 24 | $16.0M | $-73.9M | ||
| Q1 24 | $11.9M | $-68.8M | ||
| Q4 23 | $-2.3M | $-53.8M |
| Q3 25 | $53.2M | — | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $32.8M | — | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $22.6M | $30.6M | ||
| Q2 24 | $34.1M | $39.4M | ||
| Q1 24 | $32.0M | $37.3M | ||
| Q4 23 | $27.3M | $33.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-8.9M |
| Free Cash FlowOCF − Capex | — | $-8.9M |
| FCF MarginFCF / Revenue | — | -892.5% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | — | -0.14× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-45.8M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-10.9M | — | ||
| Q2 25 | $-10.5M | — | ||
| Q1 25 | $-12.5M | — | ||
| Q4 24 | $-9.9M | — | ||
| Q3 24 | $-10.2M | $-8.9M | ||
| Q2 24 | $-11.5M | $-11.7M | ||
| Q1 24 | $-12.6M | $-13.1M | ||
| Q4 23 | $-10.0M | $-11.9M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-8.9M | ||
| Q2 24 | — | $-11.7M | ||
| Q1 24 | — | $-13.2M | ||
| Q4 23 | — | $-12.1M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -892.5% | ||
| Q2 24 | — | -1190.9% | ||
| Q1 24 | — | -1302.1% | ||
| Q4 23 | — | -1149.4% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 4.2% | ||
| Q4 23 | — | 17.4% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
